{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:08:36Z","timestamp":1767650916163,"version":"3.37.3"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100017252","name":"University of Zabol","doi-asserted-by":"crossref","award":["IR-UOZ-GR-1573"],"award-info":[{"award-number":["IR-UOZ-GR-1573"]}],"id":[{"id":"10.13039\/501100017252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11011-022-01083-5","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T09:34:55Z","timestamp":1666776895000},"page":"2937-2953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prophylactic effects of cucurbitacin B in the EAE Model of multiple sclerosis by adjustment of STAT3\/IL-23\/IL-17 axis and improvement of neuropsychological symptoms"],"prefix":"10.1007","volume":"37","author":[{"given":"Samaneh","family":"Reiszadeh-Jahromi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Haddadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pegah","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4509-5336","authenticated-orcid":false,"given":"Nima","family":"Sanadgol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"1083_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-020-01339-9","author":"A Abdo","year":"2020","unstructured":"Abdo A, Tye GJ (2020) Interleukin 23 and autoimmune diseases: current and possible future therapies. Inflamm Res. https:\/\/doi.org\/10.1007\/s00011-020-01339-9","journal-title":"Inflamm Res"},{"key":"1083_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40713-4","author":"R Aharoni","year":"2019","unstructured":"Aharoni R, Schottlender N, Bar-Lev DD, Eilam R, Sela M, Tsoory M, Arnon R (2019) Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-019-40713-4","journal-title":"Sci Rep"},{"key":"1083_CR3","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S243514","author":"MR Al-Ani","year":"2020","unstructured":"Al-Ani MR, Raju TK, Hachim MY, Hachim IY, Elemam NM, Guimei M, Bendardaf R, Maghazachi AA (2020) Rituximab Prevents the Development of Experimental Autoimmune Encephalomyelitis (EAE): Comparison with Prophylactic, Therapeutic or Combinational Regimens. J Inflamm Res. https:\/\/doi.org\/10.2147\/JIR.S243514","journal-title":"J Inflamm Res"},{"key":"1083_CR4","doi-asserted-by":"publisher","DOI":"10.12816\/0006025","author":"AA Alghasham","year":"2013","unstructured":"Alghasham AA (2013) Cucurbitacins - a promising target for cancer therapy. Int J Health Sci. https:\/\/doi.org\/10.12816\/0006025","journal-title":"Int J Health Sci"},{"key":"1083_CR5","doi-asserted-by":"publisher","unstructured":"Bittner S, Afzali AM, Wiendl H, Meuth SG (2014) Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice. https:\/\/doi.org\/10.3791\/51275. JoVE","DOI":"10.3791\/51275"},{"issue":"6","key":"1083_CR6","first-page":"1270","volume":"63","author":"MA Blaskovich","year":"2003","unstructured":"Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM (2003) Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase\/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 63(6):1270\u20131279","journal-title":"Cancer Res"},{"key":"1083_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170825","author":"T Bonfiglio","year":"2017","unstructured":"Bonfiglio T, Olivero G, Merega E, Di Prisco S, Padolecchia C, Grilli M, Milanese M, Di Cesare Mannelli L, Ghelardini C, Bonanno G, Marchi M, Pittaluga A (2017) Prophylactic versus therapeutic fingolimod: restoration of presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0170825","journal-title":"PLoS One"},{"key":"1083_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-017-8915-1","author":"S Brandenburg","year":"2017","unstructured":"Brandenburg S, Turkowski K, Mueller A, Radev YT, Seidlitz S, Vajkoczy P (2017) Myeloid cells expressing high level of CD45 are associated with a distinct activated phenotype in glioma. Immunol Res. https:\/\/doi.org\/10.1007\/s12026-017-8915-1","journal-title":"Immunol Res"},{"key":"1083_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78085","author":"PR Burkett","year":"2015","unstructured":"Burkett PR, Meyer zu Horste G, Kuchroo VK (2015) Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI78085","journal-title":"J Clin Invest"},{"key":"1083_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2009.07.015","author":"KT Chan","year":"2010","unstructured":"Chan KT, Li K, Liu SL, Chu KH, Toh M, Xie WD (2010) Cucurbitacin B inhibits STAT3 and the Raf\/MEK\/ERK pathway in leukemia cell line K562. Cancer Lett. https:\/\/doi.org\/10.1016\/j.canlet.2009.07.015","journal-title":"Cancer Lett"},{"key":"1083_CR11","doi-asserted-by":"publisher","DOI":"10.1021\/np800692t","author":"C Chen","year":"2009","unstructured":"Chen C, Qiang S, Lou L, Zhao W (2009) Cucurbitane-type triterpenoids from the stems of Cucumis melo. J Nat Prod. https:\/\/doi.org\/10.1021\/np800692t","journal-title":"J Nat Prod"},{"key":"1083_CR12","doi-asserted-by":"publisher","DOI":"10.1039\/b418841c","author":"JC Chen","year":"2005","unstructured":"Chen JC, Chiu MH, Nie RL, Cordell GA, Qiu SX (2005) Cucurbitacins and cucurbitane glycosides: structures and biological activities. Nat Prod Rep. https:\/\/doi.org\/10.1039\/b418841c","journal-title":"Nat Prod Rep"},{"key":"1083_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25308","author":"Y Chen","year":"2006","unstructured":"Chen Y, Langrish CL, McKenzie B, Joyce-Shaikh B, Stumhofer JS, McClanahan T, Blumenschein W, Churakovsa T, Low J, Presta L, Hunter CA, Kastelein RA, Cua DJ (2006) Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI25308","journal-title":"J Clin Invest"},{"key":"1083_CR14","doi-asserted-by":"publisher","DOI":"10.1021\/np060213n","author":"M Clericuzio","year":"2006","unstructured":"Clericuzio M, Tabasso S, Bianco MA, Pratesi G, Beretta G, Tinelli S, Zunino F, Vidari G (2006) Cucurbitane triterpenes from the fruiting bodies and cultivated mycelia of Leucopaxillus gentianeus. J Nat Prod. https:\/\/doi.org\/10.1021\/np060213n","journal-title":"J Nat Prod"},{"key":"1083_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57940-9","author":"P Dandawate","year":"2020","unstructured":"Dandawate P, Subramaniam D, Panovich P, Standing D, Krishnamachary B, Kaushik G, Thomas SM, Dhar A, Weir SJ, Jensen RA, Anant S (2020) Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-020-57940-9","journal-title":"Sci Rep"},{"key":"1083_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43217-3","author":"N Dos Santos","year":"2019","unstructured":"Dos Santos N, Novaes LS, Dragunas G, Rodrigues JR, Brand\u00e3o W, Camarini R, Peron JPS, Munhoz CD (2019) High dose of dexamethasone protects against EAE-induced motor deficits but impairs learning\/memory in C57BL\/6 mice. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-019-43217-3","journal-title":"Sci Rep"},{"key":"1083_CR17","doi-asserted-by":"publisher","unstructured":"Durant L, Watford WT, Ramos HL, Laurence A, Vahedi G, Wei L, Takahashi H, Sun HW, Kanno Y, Powrie F, O\u2019Shea JJ (2010) Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. https:\/\/doi.org\/10.1016\/j.immuni.2010.05.003. Immunity","DOI":"10.1016\/j.immuni.2010.05.003"},{"key":"1083_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21652","author":"L Durelli","year":"2009","unstructured":"Durelli L, Conti L, Clerico M, Boselli D, Contessa G, Ripellino P, Ferrero B, Eid P, Novelli F (2009) T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.21652","journal-title":"Ann Neurol"},{"key":"1083_CR19","doi-asserted-by":"publisher","unstructured":"Egwuagu CE, Larkin Iii J (2013) Therapeutic targeting of STAT pathways in CNS autoimmune diseases. https:\/\/doi.org\/10.4161\/jkst.24134. JAKSTAT","DOI":"10.4161\/jkst.24134"},{"key":"1083_CR20","doi-asserted-by":"publisher","unstructured":"Filippi M, Rocca MA (2019) Cortical Lesions on 7-T MRI in Multiple Sclerosis: A Window into Pathogenetic Mechanisms? Radiology. https:\/\/doi.org\/10.1148\/radiol.2019190398","DOI":"10.1148\/radiol.2019190398"},{"key":"1083_CR21","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2017.4203","author":"S Garg","year":"2018","unstructured":"Garg S, Kaul SC, Wadhwa R (2018) Cucurbitacin B and cancer intervention: Chemistry, biology and mechanisms (Review). Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2017.4203","journal-title":"Int J Oncol"},{"key":"1083_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00781","author":"M Goyal","year":"2019","unstructured":"Goyal M, Khanna D, Rana PS, Khaibullin T, Martynova E, Rizvanov AA, Khaiboullina SF, Baranwal M (2019) Computational Intelligence Technique for Prediction of Multiple Sclerosis Based on Serum Cytokines. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2019.00781","journal-title":"Front Neurol"},{"key":"1083_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25119","author":"AL Greenfield","year":"2018","unstructured":"Greenfield AL, Hauser SL (2018) B-cell Therapy for Multiple Sclerosis: Entering an era. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.25119","journal-title":"Ann Neurol"},{"key":"1083_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2021.1986063","author":"C G\u00fcnayd\u0131n","year":"2021","unstructured":"G\u00fcnayd\u0131n C, \u00d6nger ME, Avc\u0131 B, Bozkurt A, Terzi M, Bilge SS (2021) Tofacitinib enhances remyelination and improves myelin integrity in cuprizone-induced mice. Immunopharmacol Immunotoxicol Advance online publication. https:\/\/doi.org\/10.1080\/08923973.2021.1986063","journal-title":"Immunopharmacol Immunotoxicol Advance online publication"},{"key":"1083_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-44682-6","author":"AM Hamilton","year":"2019","unstructured":"Hamilton AM, Forkert ND, Yang R, Wu Y, Rogers JA, Yong VW, Dunn JF (2019) Central nervous system targeted autoimmunity causes regional atrophy: a 9.4T MRI study of the EAE mouse model of Multiple Sclerosis. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-019-44682-6","journal-title":"Sci Rep"},{"key":"1083_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2020.05.049","author":"SL Hauser","year":"2020","unstructured":"Hauser SL, Cree BAC (2020) Treatment of Multiple Sclerosis: A Review. Am J Med. https:\/\/doi.org\/10.1016\/j.amjmed.2020.05.049","journal-title":"Am J Med"},{"key":"1083_CR27","doi-asserted-by":"publisher","unstructured":"Houshmand F, Barati M, Golab F, Ramezani-Sefidar S, Tanbakooie S, Tabatabaei M, Amiri M, Sanadgol N (2019) Metformin-induced AMPK activation stimulates remyelination through induction of neurotrophic factors, downregulation of NogoA and recruitment of Olig2 + precursor cells in the cuprizone murine model of multiple sclerosis. https:\/\/doi.org\/10.1007\/s40199-019-00286-z. Daru","DOI":"10.1007\/s40199-019-00286-z"},{"key":"1083_CR28","doi-asserted-by":"publisher","unstructured":"Huber AK, Wang L, Han P, Zhang X, Ekholm S, Srinivasan A, Irani DN, Segal BM, Neurology (2014) https:\/\/doi.org\/10.1212\/WNL.0000000000000908","DOI":"10.1212\/WNL.0000000000000908"},{"key":"1083_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00741.x","author":"GB Iwanski","year":"2010","unstructured":"Iwanski GB, Lee DH, En-Gal S, Doan NB, Castor B, Vogt M, Toh M, Bokemeyer C, Said JW, Thoennissen NH, Koeffler HP (2010) Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer. Br J Pharmacol. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00741.x","journal-title":"Br J Pharmacol"},{"key":"1083_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(02)00497-4","author":"B Jayaprakasam","year":"2003","unstructured":"Jayaprakasam B, Seeram NP, Nair MG (2003) Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita andreana. Cancer Lett. https:\/\/doi.org\/10.1016\/s0304-3835(02)00497-4","journal-title":"Cancer Lett"},{"key":"1083_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2014.01.022","author":"D Karussis","year":"2014","unstructured":"Karussis D (2014) The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.022","journal-title":"J Autoimmun"},{"key":"1083_CR32","doi-asserted-by":"publisher","DOI":"10.4103\/0973-7847.156314","author":"U Kaushik","year":"2015","unstructured":"Kaushik U, Aeri V, Mir SR (2015) Cucurbitacins - An insight into medicinal leads from nature. Pharmacogn Rev. https:\/\/doi.org\/10.4103\/0973-7847.156314","journal-title":"Pharmacogn Rev"},{"key":"1083_CR33","doi-asserted-by":"publisher","unstructured":"Kim KH, Lee IS, Park JY, Kim Y, An EJ, Jang HJ (2018) Cucurbitacin B Induces Hypoglycemic Effect in Diabetic Mice by Regulation of AMP-Activated Protein Kinase Alpha and Glucagon-Like Peptide-1 via Bitter Taste Receptor Signaling. https:\/\/doi.org\/10.3389\/fphar.2018.01071. Front Pharmacol","DOI":"10.3389\/fphar.2018.01071"},{"key":"1083_CR34","doi-asserted-by":"publisher","DOI":"10.3109\/08923973.2015.1085065","author":"M Kim","year":"2015","unstructured":"Kim M, Park SY, Jin ML, Park G, Son HJ (2015) Cucurbitacin B inhibits immunomodulatory function and the inflammatory response in macrophages. Immunopharmacol Immunotoxicol. https:\/\/doi.org\/10.3109\/08923973.2015.1085065","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1083_CR35","doi-asserted-by":"publisher","unstructured":"Kirkham BW, Kavanaugh A, Reich K (2014) Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis. https:\/\/doi.org\/10.1111\/imm.12142. Immunology","DOI":"10.1111\/imm.12142"},{"key":"1083_CR36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041257","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20041257","journal-title":"J Exp Med"},{"key":"1083_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-016-1631-4","author":"H Lassmann","year":"2017","unstructured":"Lassmann H, Bradl M (2017) Multiple sclerosis: experimental models and reality. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-016-1631-4","journal-title":"Acta Neuropathol"},{"key":"1083_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2011.03.001","author":"DH Lee","year":"2011","unstructured":"Lee DH, Thoennissen NH, Goff C, Iwanski GB, Forscher C, Doan NB, Said JW, Koeffler HP (2011) Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma. Cancer Lett. https:\/\/doi.org\/10.1016\/j.canlet.2011.03.001","journal-title":"Cancer Lett"},{"key":"1083_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2015.10.006","author":"E Leray","year":"2016","unstructured":"Leray E, Moreau T, Fromont A, Edan G (2016) Epidemiology of multiple sclerosis. Rev Neurol (Paris). https:\/\/doi.org\/10.1016\/j.neurol.2015.10.006","journal-title":"Rev Neurol (Paris)"},{"key":"1083_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08823-4","author":"H Li","year":"2021","unstructured":"Li H, Tsokos GC (2021) IL-23\/IL-17 Axis in Inflammatory Rheumatic Diseases. Clin Rev Allergy Immunol. https:\/\/doi.org\/10.1007\/s12016-020-08823-4","journal-title":"Clin Rev Allergy Immunol"},{"key":"1083_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-217","author":"L Lin","year":"2010","unstructured":"Lin L, Deangelis S, Foust E, Fuchs J, Li C, Li PK, Schwartz EB, Lesinski GB, Benson D, L\u00fc J, Hoyt D, Lin J (2010) A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells. Mol Cancer. https:\/\/doi.org\/10.1186\/1476-4598-9-217","journal-title":"Mol Cancer"},{"key":"1083_CR42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301513","author":"Y Liu","year":"2014","unstructured":"Liu Y, Holdbrooks AT, De Sarno P, Rowse AL, Yanagisawa LL, McFarland BC, Harrington LE, Raman C, Sabbaj S, Benveniste EN, Qin H (2014) Therapeutic efficacy of suppressing the Jak\/STAT pathway in multiple models of experimental autoimmune encephalomyelitis. J Immunol. https:\/\/doi.org\/10.4049\/jimmunol.1301513","journal-title":"J Immunol"},{"key":"1083_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.53","author":"E Lubberts","year":"2015","unstructured":"Lubberts E (2015) The IL-23-IL-17 axis in inflammatory arthritis. Nat Rev Rheumatol. https:\/\/doi.org\/10.1038\/nrrheum.2015.53","journal-title":"Nat Rev Rheumatol"},{"key":"1083_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1698","author":"MJ McGeachy","year":"2009","unstructured":"McGeachy MJ, Chen Y, Tato CM, Laurence A, Joyce-Shaikh B, Blumenschein WM, McClanahan TK, O\u2019Shea JJ, Cua DJ (2009) The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol. https:\/\/doi.org\/10.1038\/ni.1698","journal-title":"Nat Immunol"},{"key":"1083_CR45","doi-asserted-by":"publisher","unstructured":"Migliore S, Ghazaryan A, Simonelli I, Pasqualetti P, Squitieri F, Curcio G, Landi D, Palmieri MG, Moffa F, Filippi MM, Vernieri F (2017) Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability. https:\/\/doi.org\/10.1155\/2017\/7404289. Behav Neurol","DOI":"10.1155\/2017\/7404289"},{"key":"1083_CR46","doi-asserted-by":"publisher","unstructured":"Monin L, Gaffen SL (2018) Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a028522","DOI":"10.1101\/cshperspect.a028522"},{"key":"1083_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2010.01.014","author":"AC Murphy","year":"2010","unstructured":"Murphy AC, Lalor SJ, Lynch MA, Mills KH (2010) Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun. https:\/\/doi.org\/10.1016\/j.bbi.2010.01.014","journal-title":"Brain Behav Immun"},{"key":"1083_CR48","doi-asserted-by":"publisher","DOI":"10.1021\/np50113a004","author":"LL Musza","year":"1994","unstructured":"Musza LL, Speight P, McElhiney S, Barrow CJ, Gillum AM, Cooper R, Killar LM (1994) Cucurbitacins, cell adhesion inhibitors from Conobea scoparioides. J Nat Prod. https:\/\/doi.org\/10.1021\/np50113a004","journal-title":"J Nat Prod"},{"key":"1083_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00516","author":"S Omura","year":"2019","unstructured":"Omura S, Sato F, Martinez NE, Park AM, Fujita M, Kennett NJ, Cvek U, Minagar A, Alexander JS, Tsunoda I (2019) Bioinformatics Analyses Determined the Distinct CNS and Peripheral Surrogate Biomarker Candidates Between Two Mouse Models for Progressive Multiple Sclerosis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.00516","journal-title":"Front Immunol"},{"key":"1083_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2015.10.022","author":"SY Park","year":"2015","unstructured":"Park SY, Kim YH, Park G (2015) Cucurbitacins attenuate microglial activation and protect from neuroinflammatory injury through Nrf2\/ARE activation and STAT\/NF-\u03baB inhibition. Neurosci Lett. https:\/\/doi.org\/10.1016\/j.neulet.2015.10.022","journal-title":"Neurosci Lett"},{"key":"1083_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202371","author":"DD Patel","year":"2013","unstructured":"Patel DD, Lee DM, Kolbinger F, Antoni C (2013) Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202371","journal-title":"Ann Rheum Dis"},{"key":"1083_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00400","author":"G Piras","year":"2013","unstructured":"Piras G, Rattazzi L, McDermott A, Deacon R, D\u2019Acquisto F (2013) Emotional change-associated T cell mobilization at the early stage of a mouse model of multiple sclerosis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2013.00400","journal-title":"Front Immunol"},{"key":"1083_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2017.11.028","author":"M Poorebrahim","year":"2018","unstructured":"Poorebrahim M, Asghari M, Abazari MF, Askari H, Sadeghi S, Taheri-Kafrani A, Nasr-Esfahani MH, Ghoraeian P, Aleagha MN, Arab SS, Kennedy D, Montaseri A, Mehranfar M, Sanadgol N (2018) Immunomodulatory effects of a rationally designed peptide mimetic of human IFN\u03b2 in EAE model of multiple sclerosis. Prog Neuropsychopharmacol Biol Psychiatry. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.11.028","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1083_CR54","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1117218109","author":"H Qin","year":"2012","unstructured":"Qin H, Yeh WI, De Sarno P, Holdbrooks AT, Liu Y, Muldowney MT, Reynolds SL, Yanagisawa LL, Fox TH 3rd, Park K, Harrington LE, Raman C, Benveniste EN (2012) Signal transducer and activator of transcription-3\/suppressor of cytokine signaling-3 (STAT3\/SOCS3) axis in myeloid cells regulates neuroinflammation. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.1117218109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1083_CR56","doi-asserted-by":"publisher","unstructured":"Rasool R, Ullah I, Shahid S, Mubeen B, Imam SS, Alshehri S, Ghoneim MM, Alzarea SI, Murtaza BN, Nadeem MS, Kazmi I (2022) In Vivo Assessment of the Ameliorative Impact of Some Medicinal Plant Extracts on Lipopolysaccharide-Induced Multiple Sclerosis in Wistar Rats. https:\/\/doi.org\/10.3390\/molecules27051608. Molecules","DOI":"10.3390\/molecules27051608"},{"key":"1083_CR57","doi-asserted-by":"publisher","DOI":"10.3109\/08820139.2015.1085391","author":"N Ramroodi","year":"2015","unstructured":"Ramroodi N, Khani M, Ganjali Z, Javan MR, Sanadgol N, Khalseh R, Ravan H, Sanadgol E, Abdollahi M (2015) Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis. Immunol Invest. https:\/\/doi.org\/10.3109\/08820139.2015.1085391","journal-title":"Immunol Invest"},{"key":"1083_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00405","author":"S Rangaraju","year":"2018","unstructured":"Rangaraju S, Raza SA, Li NX, Betarbet R, Dammer EB, Duong D, Lah JJ, Seyfried NT, Levey AI (2018) Differential Phagocytic Properties of CD45low Microglia and CD45high Brain Mononuclear Phagocytes-Activation and Age-Related Effects. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.00405","journal-title":"Front Immunol"},{"key":"1083_CR59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1401483","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple Sclerosis. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMra1401483","journal-title":"N Engl J Med"},{"key":"1083_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-019-02865-7","author":"S Reiszadeh-Jahromi","year":"2019","unstructured":"Reiszadeh-Jahromi S, Sepand MR, Ramezani-Sefidar S, Shahlaei M, Moradi S, Yazdankhah M, Sanadgol N (2019) Sepantronium Bromide (YM155), A Small Molecule Survivin Inhibitor, Promotes Apoptosis by Induction of Oxidative Stress, Worsens the Behavioral Deficits and Develops an Early Model of Toxic Demyelination: In Vivo and In-Silico Study. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-019-02865-7","journal-title":"Neurochem Res"},{"key":"1083_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.21125","author":"G Riccitelli","year":"2011","unstructured":"Riccitelli G, Rocca MA, Pagani E, Rodegher ME, Rossi P, Falini A, Comi G, Filippi M (2011) Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype. Hum Brain Mapp. https:\/\/doi.org\/10.1002\/hbm.21125","journal-title":"Hum Brain Mapp"},{"key":"1083_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577603","author":"RA Rotolo","year":"2021","unstructured":"Rotolo RA, Demuro J, Drummond G, Little C, Johns LD, Betz AJ (2021) Prophylactic exposure to oral riluzole reduces the clinical severity and immune-related biomarkers of experimental autoimmune encephalomyelitis. J Neuroimmunol. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577603","journal-title":"J Neuroimmunol"},{"key":"1083_CR63","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-019-00019-8","author":"N Sanadgol","year":"2020","unstructured":"Sanadgol N, Barati M, Houshmand F, Hassani S, Clarner T, Shahlaei M, Golab F (2020) Metformin accelerates myelin recovery and ameliorates behavioral deficits in the animal model of multiple sclerosis via adjustment of AMPK\/Nrf2\/mTOR signaling and maintenance of endogenous oligodendrogenesis during brain self-repairing period. Pharmacol Rep. https:\/\/doi.org\/10.1007\/s43440-019-00019-8","journal-title":"Pharmacol Rep"},{"key":"1083_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-017-0099-9","author":"N Sanadgol","year":"2018","unstructured":"Sanadgol N, Golab F, Askari H, Moradi F, Ajdary M, Mehdizadeh M (2018) Alpha-lipoic acid mitigates toxic-induced demyelination in the corpus callosum by lessening of oxidative stress and stimulation of polydendrocytes proliferation. Metab Brain Dis. https:\/\/doi.org\/10.1007\/s11011-017-0099-9","journal-title":"Metab Brain Dis"},{"key":"1083_CR65","doi-asserted-by":"publisher","DOI":"10.14715\/cmb\/2016.62.12.5","author":"N Sanadgol","year":"2016","unstructured":"Sanadgol N, Golab F, Mostafaie A, Mehdizadeh M, Abdollahi M, Sharifzadeh M, Ravan H (2016b) Ellagic acid ameliorates cuprizone-induced acute CNS inflammation via restriction of microgliosis and down-regulation of CCL2 and CCL3 pro-inflammatory chemokines. Cell Mol Biol. https:\/\/doi.org\/10.14715\/cmb\/2016.62.12.5","journal-title":"Cell Mol Biol"},{"key":"1083_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2018.01.023","author":"N Sanadgol","year":"2016","unstructured":"Sanadgol N, Golab F, Mostafaie A, Mehdizadeh M, Khalseh R, Mahmoudi M, Abdollahi M, Vakilzadeh G, Taghizadeh G, Sharifzadeh M (2016a) Low, but not high, dose triptolide controls neuroinflammation and improves behavioral deficits in toxic model of multiple sclerosis by dampening of NF-\u03baB activation and acceleration of intrinsic myelin repair. Toxicol Appl Pharmacol. https:\/\/doi.org\/10.1016\/j.taap.2018.01.023","journal-title":"Toxicol Appl Pharmacol"},{"key":"1083_CR67","doi-asserted-by":"publisher","DOI":"10.2174\/1389450118666161108124414","author":"N Sanadgol","year":"2017","unstructured":"Sanadgol N, Zahedani SS, Sharifzadeh M, Khalseh R, Barbari GR, Abdollahi M (2017) Recent Updates in Imperative Natural Compounds for Healthy Brain and Nerve Function: A Systematic Review of Implications for Multiple Sclerosis. Curr Drug Targets. https:\/\/doi.org\/10.2174\/1389450118666161108124414","journal-title":"Curr Drug Targets"},{"key":"1083_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3260","author":"G Schett","year":"2013","unstructured":"Schett G, Elewaut D, McInnes IB, Dayer JM, Neurath MF (2013) How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy. Nat Med. https:\/\/doi.org\/10.1038\/nm.3260","journal-title":"Nat Med"},{"key":"1083_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2013.11.040","author":"CR Seo","year":"2014","unstructured":"Seo CR, Yang DK, Song NJ, Yun UJ, Gwon AR, Jo DG, Cho JY, Yoon K, Ahn JY, Nho CW, Park WJ, Yang SY, Park KW (2014) Cucurbitacin B and cucurbitacin I suppress adipocyte differentiation through inhibition of STAT3 signaling. Food Chem Toxicol. https:\/\/doi.org\/10.1016\/j.fct.2013.11.040","journal-title":"Food Chem Toxicol"},{"key":"1083_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27797","author":"MK Shirazi","year":"2019","unstructured":"Shirazi MK, Azarnezhad A, Abazari MF, Poorebrahim M, Ghoraeian P, Sanadgol N, Bokharaie H, Heydari S, Abbasi A, Kabiri S, Aleagha MN, Enderami SE, Dashtaki AS, Askari H (2019) The role of nitric oxide signaling in renoprotective effects of hydrogen sulfide against chronic kidney disease in rats: Involvement of oxidative stress, autophagy and apoptosis. J Cell Physiol. https:\/\/doi.org\/10.1002\/jcp.27797","journal-title":"J Cell Physiol"},{"key":"1083_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/srep21860","author":"S Shukla","year":"2016","unstructured":"Shukla S, Sinha S, Khan S, Kumar S, Singh K, Mitra K, Maurya R, Meeran SM (2016) Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt\/\u03b2-catenin signaling axis. Sci Rep. https:\/\/doi.org\/10.1038\/srep21860","journal-title":"Sci Rep"},{"key":"1083_CR72","doi-asserted-by":"publisher","unstructured":"Sorensen PS, Sellebjerg F, Hartung HP, Montalban X, Comi G, Tintor\u00e9 M (2020) The apparently milder course of multiple sclerosis: changes in the diagnostic criteria, therapy and natural history. https:\/\/doi.org\/10.1093\/brain\/awaa145. Brain","DOI":"10.1093\/brain\/awaa145"},{"key":"1083_CR73","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004977","author":"JF Sumowski","year":"2018","unstructured":"Sumowski JF, Benedict R, Enzinger C, Filippi M, Geurts JJ, Hamalainen P, Hulst H, Inglese M, Leavitt VM, Rocca MA, Rosti-Otajarvi EM, Rao S (2018) Cognition in multiple sclerosis: State of the field and priorities for the future. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000004977","journal-title":"Neurology"},{"key":"1083_CR74","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/170316","author":"T Takemiya","year":"2013","unstructured":"Takemiya T, Takeuchi C (2013) Traveled distance is a sensitive and accurate marker of motor dysfunction in a mouse model of multiple sclerosis. ISRN Neurosci. https:\/\/doi.org\/10.1155\/2013\/170316","journal-title":"ISRN Neurosci"},{"key":"1083_CR75","doi-asserted-by":"publisher","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O (2018) Multiple sclerosis. https:\/\/doi.org\/10.1016\/S0140-6736(18)30481-1. Lancet","DOI":"10.1016\/S0140-6736(18)30481-1"},{"key":"1083_CR76","doi-asserted-by":"publisher","unstructured":"Treaba CA, Granberg TE, Sormani MP, Herranz E, Ouellette RA, Louapre C, Sloane JA, Kinkel RP, Mainero C (2019) Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI. https:\/\/doi.org\/10.1148\/radiol.2019181719. Radiology","DOI":"10.1148\/radiol.2019181719"},{"key":"1083_CR77","doi-asserted-by":"publisher","unstructured":"Tryfonos C, Mantzorou M, Fotiou D, Vrizas M, Vadikolias K, Pavlidou E, Giaginis C (2019) Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives. Medicines (Basel). https:\/\/doi.org\/10.3390\/medicines6030095","DOI":"10.3390\/medicines6030095"},{"key":"1083_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2016.01.013","author":"R van den Berg","year":"2016","unstructured":"van den Berg R, Laman JD, van Meurs M, Hintzen RQ, Hoogenraad CC (2016) Rotarod motor performance and advanced spinal cord lesion image analysis refine assessment of neurodegeneration in experimental autoimmune encephalomyelitis. J Neurosci Methods. https:\/\/doi.org\/10.1016\/j.jneumeth.2016.01.013","journal-title":"J Neurosci Methods"},{"key":"1083_CR79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2008.00899.x","author":"N Wakimoto","year":"2008","unstructured":"Wakimoto N, Yin D, O\u2019Kelly J, Haritunians T, Karlan B, Said J, Xing H, Koeffler HP (2008) Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo. Cancer Sci. https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00899.x","journal-title":"Cancer Sci"},{"key":"1083_CR80","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007035","author":"MT Wallin","year":"2019","unstructured":"Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG, US (2019) Multiple Sclerosis Prevalence Workgroup. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000007035","journal-title":"Neurology"},{"key":"1083_CR81","doi-asserted-by":"publisher","unstructured":"Wang Q, Ding SL, Li Y, Royall J, Feng D, Lesnar P, Graddis N, Naeemi M, Facer B, Ho A, Dolbeare T, Blanchard B, Dee N, Wakeman W, Hirokawa KE, Szafer A, Sunkin SM, Oh SW, Bernard A, Phillips JW, Hawrylycz M, Koch C, Zeng H, Harris JA, Ng L (2020) The Allen Mouse Brain Common Coordinate Framework: A 3D Reference Atlas. Cell. https:\/\/doi.org\/10.1016\/j.cell.2020.04.007","DOI":"10.1016\/j.cell.2020.04.007"},{"key":"1083_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2012.01.033","author":"C Wiart","year":"2012","unstructured":"Wiart C (2012) The definition and significance of Cucurbitacin B a STAT3 inhibitors. Cancer Lett. https:\/\/doi.org\/10.1016\/j.canlet.2012.01.033","journal-title":"Cancer Lett"},{"key":"1083_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106210","author":"P Xin","year":"2020","unstructured":"Xin P, Xu X, Deng C, Liu S, Wang Y, Zhou X, Ma H, Wei D, Sun S (2020) The role of JAK\/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol. https:\/\/doi.org\/10.1016\/j.intimp.2020.106210","journal-title":"Int Immunopharmacol"},{"key":"1083_CR84","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.2581","author":"M Zhang","year":"2014","unstructured":"Zhang M, Bian ZG, Zhang Y, Wang JH, Kan L, Wang X, Niu HY, He P (2014) Cucurbitacin B inhibits proliferation and induces apoptosis via STAT3 pathway inhibition in A549 lung cancer cells. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2014.2581","journal-title":"Mol Med Rep"},{"key":"1083_CR85","doi-asserted-by":"publisher","unstructured":"Zhang M, Sun C, Shan X, Yang X, Li-Ling J, Deng Y (2010) Inhibition of pancreatic cancer cell growth by cucurbitacin B through modulation of signal transducer and activator of transcription 3 signaling. https:\/\/doi.org\/10.1097\/MPA.0b013e3181ce719e. Pancreas","DOI":"10.1097\/MPA.0b013e3181ce719e"},{"key":"1083_CR86","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-008-0780-0","author":"M Zhang","year":"2009","unstructured":"Zhang M, Zhang H, Sun C, Shan X, Yang X, Li-Ling J, Deng Y (2009) Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B. Cancer Chemother Pharmacol. https:\/\/doi.org\/10.1007\/s00280-008-0780-0","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-01083-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-022-01083-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-022-01083-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T03:29:55Z","timestamp":1668655795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-022-01083-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":85,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1083"],"URL":"https:\/\/doi.org\/10.1007\/s11011-022-01083-5","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"type":"print","value":"0885-7490"},{"type":"electronic","value":"1573-7365"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"29 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the experiments were performed according to the approved protocols (Helsinki declaration, 2008) and Iranian national guidelines for the care and use of laboratory animals in scientific research (August 2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}